Comcast Corp (NYSE:CCZ) Sees Significantly Lower Trading Volume
Aer Lingus announces Seattle service
Google Adds Developer Features, Including a Push Notification API
The Rock's daughter Simone Garcia is 2018 Golden Globe Ambassador
Adobe Systems Incorporated (ADBE) Holdings Lowered by Cullen Frost Bankers Inc
Toronto Dominion Bank Buys 56539 Shares of Boston Scientific Corporation (BSX)
14 November 2017, 06:44 | Casey Mitchell
Creative Planning raised its position in shares of Boston Scientific Corporation by 5.5% during the 2nd quarter. Bank of Montreal Can now owns 576,861 shares of the medical equipment provider's stock worth $15,990,000 after buying an additional 65,725 shares during the period. Prudential Financial Inc. now owns 4,762,674 shares of the medical equipment provider's stock worth $138,928,000 after buying an additional 2,850,630 shares in the last quarter. Janus Henderson Group PLC increased its stake in shares of Boston Scientific Corporation by 22,491.6% in the second quarter. Boston Scientific Corporation's revenue was up 5.6% on a year-over-year basis. equities research analysts expect that Boston Scientific Corporation will post 1.25 earnings per share for the current fiscal year. The value of the investment in (BSX) went from $11,937,000 to $11,934,000 decreasing 0.0% for the reporting period.
On November 7 Royal Bank Of Canada maintained a company rating of "Buy" projecting a price of $31.00. Finally, SunTrust Banks, Inc. restated a "buy" rating and issued a $34.00 price target on shares of Boston Scientific Corporation in a research note on Monday, October 2nd. Finally, Ironwood Investment Counsel LLC acquired a new stake in Boston Scientific Corporation in the 3rd quarter valued at approximately $204,000. They set a "buy" rating and a $36.00 price objective on the stock. Analysts have a mean recommendation of 1.80 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Current price places the company's stock 5.99% away from its 200-day simple moving average, -1.31%, away from the 50-day average and also -0.86% away from 20-day average.
The company is down by 0.14% since yesterday's close of 28.36. The company has a market capitalization of $38,943.84, a price-to-earnings ratio of 23.25, a P/E/G ratio of 2.19 and a beta of 1.00. UBS AG restated a "buy" rating and issued a $31.00 price target (up from $30.00) on shares of Boston Scientific Corporation in a research note on Tuesday, August 1st. The quick ratio, on the other hand, is 0.5 indicating the company's current short-term liquidity. (NYSE:BSX) last released its earnings results on Wednesday, October 26th. The medical equipment provider reported $0.31 earnings per share for the quarter, hitting analysts' consensus estimates of $0.31. The business had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.21 billion. Bellevue Group AG bought a new position in Boston Scientific Corp. during the first quarter worth $9,405,000. The company's revenue for the quarter was up 5.6% compared to the same quarter past year. The value of the investment in Boston Scientific Corp decreased from $11,937,000 to $11,934,000 a change of 0.0% since the last quarter.
In other Boston Scientific Corporation news, EVP Timothy A. Pratt sold 10,104 shares of the stock in a transaction that occurred on Friday, September 1st. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The shares were sold at an average price of $27.28, for a total transaction of $1,555,805.68. Following the sale, the executive vice president now directly owns 185,742 shares of the company's stock, valued at $5,100,475.32. Trading volume for Boston Scientific Corporation was 4.72 Million in its previous trading session. Insiders own 1.31% of the company's stock. If you are reading this piece on another domain, it was stolen and reposted in violation of USA and worldwide trademark and copyright law.
With today's market cap for Boston Scientific Corporation, traders can easily name it as one of the major player in its Medical Appliances & Equipment industry. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP), Endoscopy, Urology and Pelvic Health, and Neuromodulation.
$1.31 EPS Expected for Costco Wholesale Corporation (COST)
Currently, 437.8 million total shares are owned by the public and among those 434.07 million shares have been available to trade. The institutional investor owned 3,367,017 shares of the retailer's stock after selling 250,903 shares during the quarter.
Lord of the Rings Franchise Gets TV Spinoff
That was a winning formula for attracting Hollywood talent, awards and buzz, though not Prime subscribers around the world. Amazon has committed to produce multiple seasons of a new television series based on the epic fantasy novel.
First Pokemon Ultra Sun And Ultra Moon Review Score
For a wider look at what critics think of Pokemon Ultra Sun and Ultra Moon , be sure to visit GameSpot sister site Metacritic . Starting today, November 13, Pokemon GO users can find new avatar items straight from the Alola region.